94 related articles for article (PubMed ID: 1145196)
1. Lactosyl ceramidosis: normal activity for two lactosyl ceramide beta-galactosidases.
Wenger DA; Sattler M; Clark C; Tanaka H; Suzuki K; Dawson G
Science; 1975 Jun; 188(4195):1310-2. PubMed ID: 1145196
[TBL] [Abstract][Full Text] [Related]
2. Lactosyl ceramidosis: deficient activity of neutral beta-galactosidase in liver and cultivated fibroblasts?
Burton BK; Ben-Yoseph Y; Nadler HL
Clin Chim Acta; 1978 Sep; 88(3):483-93. PubMed ID: 29729
[TBL] [Abstract][Full Text] [Related]
3. Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase.
Wenger DA; Sattler M; Hiatt W
Proc Natl Acad Sci U S A; 1974 Mar; 71(3):854-7. PubMed ID: 4522795
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificities of the two genetically distinct human brain beta-galactosidases.
Tanaka H; Suzuki K
Brain Res; 1977 Feb; 122(2):325-35. PubMed ID: 13910
[TBL] [Abstract][Full Text] [Related]
5. Studies on galactosyl ceramide and lactosyl ceramide beta-galactosidase.
Wenger DA
Chem Phys Lipids; 1974 Dec; 13(4):327-9. PubMed ID: 4452215
[No Abstract] [Full Text] [Related]
6. Lactosyl ceramidosis: catabolic enzyme defect of glycosphingolipid metabolism.
Dawson G; Stein AO
Science; 1970 Oct; 170(3957):556-8. PubMed ID: 5507210
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the properties and bile salt specificities of galactosylceramide and lactosyl ceramide beta-galactosidase activities in human leucocytes and fibroblasts.
Poulos A; Beckman K
Clin Chim Acta; 1980 Feb; 101(2-3):277-85. PubMed ID: 6766828
[TBL] [Abstract][Full Text] [Related]
8. Mucolipidosis II and III: different residual activity of beta-galactosidase in cultured fibroblasts.
Leroy JG; O'Brien JS
Clin Genet; 1976 May; 9(5):533-9. PubMed ID: 1269176
[TBL] [Abstract][Full Text] [Related]
9. Radiochemical decomposition of lactosyl-6-( 3 H)-ceramide.
Mumford RA; Raghavan SS; Rhoads DB; Kanfer JN
Lipids; 1973 Apr; 8(4):238-40. PubMed ID: 4695137
[No Abstract] [Full Text] [Related]
10. Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.
Rylova SN; Somova OG; Zubova ES; Dudnik LB; Kogtev LS; Kozlov AM; Alesenko AV; Dyatlovitskaya EV
Biochemistry (Mosc); 1999 Apr; 64(4):437-41. PubMed ID: 10231598
[TBL] [Abstract][Full Text] [Related]
11. Role of lysosomal acid ceramidase in the metabolism of ceramide in human skin fibroblasts.
Chen WW; Moser AB; Moser HW
Arch Biochem Biophys; 1981 May; 208(2):444-55. PubMed ID: 7259198
[No Abstract] [Full Text] [Related]
12. Positive feedback control of neutral sphingomyelinase activity by ceramide.
Jaffrézou JP; Maestre N; de Mas-Mansat V; Bezombes C; Levade T; Laurent G
FASEB J; 1998 Aug; 12(11):999-1006. PubMed ID: 9707172
[TBL] [Abstract][Full Text] [Related]
13. Permeability barrier disorder in Niemann-Pick disease: sphingomyelin-ceramide processing required for normal barrier homeostasis.
Schmuth M; Man MQ; Weber F; Gao W; Feingold KR; Fritsch P; Elias PM; Holleran WM
J Invest Dermatol; 2000 Sep; 115(3):459-66. PubMed ID: 10951284
[TBL] [Abstract][Full Text] [Related]
14. Purification of G-M-1-ganglioside and ceramide lactoside beta-galactosidase from rabbit brain.
Callahan JW; Gerrie J
Biochim Biophys Acta; 1975 May; 391(1):141-53. PubMed ID: 237552
[TBL] [Abstract][Full Text] [Related]
15. Juvenile GM1 gangliosidosis. Occurrence with absence of two beta-galactosidase components.
Lowden JA; Callahan JW; Norman MG; Thain M; Prichard JS
Arch Neurol; 1974 Sep; 31(3):200-3. PubMed ID: 4368854
[No Abstract] [Full Text] [Related]
16. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition. Effect of prolonged exercise.
Dobrzyń A; Górski J
Am J Physiol Endocrinol Metab; 2002 Feb; 282(2):E277-85. PubMed ID: 11788358
[TBL] [Abstract][Full Text] [Related]
17. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
Gerritsen ME; Shen CP; Perry CA
Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577
[TBL] [Abstract][Full Text] [Related]
18. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death.
Major CD; Gao ZY; Wolf BA
Diabetes; 1999 Jul; 48(7):1372-80. PubMed ID: 10389841
[TBL] [Abstract][Full Text] [Related]
19. Pattern of beta-galactosidase deficiency in GM1-gangliosidosis type 1 and type 2.
Orii T; Sukegawa K; Minami R; Tsugawa S; Nakao T
Tohoku J Exp Med; 1973 Jul; 110(3):309-10. PubMed ID: 4757675
[No Abstract] [Full Text] [Related]
20. The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase.
Lei X; Zhang S; Bohrer A; Bao S; Song H; Ramanadham S
Biochemistry; 2007 Sep; 46(35):10170-85. PubMed ID: 17685585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
